Skip to content

Category: Biotechnology

Island Pharmaceuticals doses first cohort in ISLA-101 Single Ascending Dose study

By API User

The Single Ascending Dose study is a dose escalation study, in which three cohorts of healthy subjects will receive escalating doses of ISLA-101 Study will ensure that administered doses can safely achieve blood concentrations of ISLA-101 that are predicted to be effective against the dengue virus Data readout from the study is expected in early 2024   MELBOURNE Australia, 24 November 2023: Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; “Island”; “the Company”) is pleased to announce that it has dosed the first cohort in its Single Ascending Dose (SAD) study for … Continued

ASX Hopeful Aegros Appoints Ex-MP As Advisory Committee Chair

By API User

Australia’s leading blood fractionator announces a trio of strategic advisor appointments as it lays the groundwork for an IPO    Aegros has established a Strategic Advisory Committee (SAC), to provide advice to the Board in preparation for the company’s Initial Public Offering (IPO). The high-profile SAC members will be drawn from experts in their fields, … Continued

Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson’s Disease Patients Worldwide in Japan

By API User

Biostar Stem Cell Research Institute has received approval from Japan’s Ministry of Health, Labor and Welfare to Treat Parkinson’s Disease. The combination of intravenous and spinal cord cavity administration is expected to increase the effectiveness of the treatment. This therapy may also be effective for other incurable neurological diseases. The stem cells are cultured in … Continued

Servatus launches new microbiome-based consumer skincare range

By API User

Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, is pleased to announce the launch of its new microbiome-based over-the-counter (OTC) biomiq skincare range. Leading the charge in one of the most exciting new areas in skincare, biomiq utilises the skin microbiome to address the underlying causes of certain skin conditions, while … Continued

The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros

By API User

VILNIUS, LITHUANIA / ACCESSWIRE / November 16, 2023 / Northway Group is embarking on a project to establish Europe’s largest biotechnology hub, BIO CITY, in Vilnius, the capital of Lithuania. It includes 6 large biotechnological complexes – 4 state-of-the-art GMP manufacturing plants and 2 advanced scientific research centres – that will be built in an … Continued

Media experts – National Agriculture Day

By API User

NATIONAL AGRICULTURE DAY   Friday November 17 is National Agriculture Day. Experts from La Trobe University are available to discuss key themes relating to Australia’s agriculture future. Associate Professor Jim Radford Department of Environment and Genetics, School of Agriculture, Biomedicine and Environment Dr Radford can speak to: outcomes of landscape change on ecological communities and native wildlife in agricultural landscapes practices … Continued

Australian-invented drug technology used for treatment of anxiety disorders significantly reduces stress hormone response: Phase 2a clinical trial results

By API User

A unique drug technology platform developed by Monash University researchers in partnership with Boston-based biotherapeutics company, PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), has reached another exciting milestone with the successful completion of a Phase 2a clinical trial of ‘LYT-300’ an oral version of the drug allopregnanolone.     The randomised, placebo-controlled, proof-of-concept trial has … Continued

New national centre to transform Australia’s homegrown medicine capabilities launches in Melbourne

By API User

MedChem Australia, a first-of-its-kind national initiative connecting three of the nation’s top medicinal chemistry groups from Monash University, WEHI and the University of Sydney, will accelerate promising early-stage drug discovery projects towards clinical trials and, ultimately, create new medicines for a broad range of diseases.   The initiative was established with $9.75 million in funding from … Continued